Back to News
Market Impact: 0.2

Can't Buy SpaceX Yet? Here Are 4 Ways to Get in Before the IPO.

SOFIDXYZGOOGLSATS
Private Markets & VentureIPOs & SPACsInvestor Sentiment & PositioningTechnology & InnovationCompany Fundamentals
Can't Buy SpaceX Yet? Here Are 4 Ways to Get in Before the IPO.

SpaceX has reportedly filed plans to go public, but investors can already gain exposure through private-market funds and public vehicles such as SoFi's Cosmos Fund, Ark Venture Fund, ERShares Private-Public Crossover ETF, and Destiny Tech 100. The article highlights SpaceX as the largest holding in several of these vehicles, including 17% of Ark Venture Fund, 27% of XOVR, and 16.2% of DXYZ. It also notes indirect exposure through Alphabet, which owns more than 6% of SpaceX, and EchoStar via a pending deal.

Analysis

The common thread here is that SpaceX exposure has become a liquid proxy trade for late-stage private growth, but the trade is structurally inefficient. Public wrappers with concentrated SpaceX exposure are likely to trade at a persistent premium/discount cycle driven more by retail sentiment than by NAV discipline, creating a mismatch between the underlying mark-up cadence and the market’s ability to arb the spread. That sets up a recurring pattern: when private-market optimism is strong, these vehicles can outperform on narrative; when funding conditions tighten, they can gap down faster than the underlying private asset because they lack a natural buyer base. GOOGL is the cleaner second-order beneficiary because the market tends to underappreciate how strategic stakes in frontier assets improve optionality without meaningful balance-sheet strain. The real value is not the current mark, but the signaling effect: owning a stake in the most visible private-space franchise helps defend investor perception that big tech remains the cheapest way to own moonshot innovation. SATS is more interesting as a derivative call on any SpaceX-related asset reallocation or transaction approval; the upside is binary and regulatory, which makes the name more sensitive to headline flow than to fundamentals. The contrarian risk is that the “buy now, IPO later” framing may be peak-retail psychology. If the IPO process drags or valuation expectations reset, the public proxies could de-rate even if SpaceX itself continues compounding privately. That creates a window for a mean-reversion short in the highest-premium wrappers, especially if the broader speculative-growth tape weakens over the next 1-3 months. The market is paying for immediacy here; the risk is that liquidity and access are being mistaken for value creation.